Aurigene Discovery Technologies Email Format

Biotechnology ResearchKarnataka, India201-500 Employees

Based in Bangalore, Aurigene Discovery Technologies has rebranded as Aurigene Oncology Limited and operates as the oncology-focused arm of Dr. Reddy's Laboratories Limited, a wholly owned subsidiary within the group. The organization conducts biotechnology research and forms collaborations with industry and public partners to pursue cancer therapies, including a cell therapy program with Edity Therapeutics and partnerships with Olema Pharmaceuticals, the ICMR, Indian Immunologicals Limited, Mynvax, and ImmunoACT.

Recent activity includes presenting at the AACR-NCI-EORTC International Conference in 2025 to share research developments and launching new proteolysis-targeted candidate compounds in collaboration with Olema Pharmaceuticals in 2026. These efforts indicate a focus on expanding oncology programs and exploring novel therapeutic approaches for difficult-to-treat cancers.

Sign up for free to view info

Company overview Employee directory